DE2152814A1 - Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung - Google Patents

Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung

Info

Publication number
DE2152814A1
DE2152814A1 DE19712152814 DE2152814A DE2152814A1 DE 2152814 A1 DE2152814 A1 DE 2152814A1 DE 19712152814 DE19712152814 DE 19712152814 DE 2152814 A DE2152814 A DE 2152814A DE 2152814 A1 DE2152814 A1 DE 2152814A1
Authority
DE
Germany
Prior art keywords
group
compound
formula
pyrimidine
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19712152814
Other languages
German (de)
English (en)
Inventor
Barbara Cahpel Hill N C Roth (V St A ), Stuart, Alexander, Bromely, Paterson, Thomas, Gravesend, Kent (Großbritannien)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB963871*[A external-priority patent/GB1375162A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2152814A1 publication Critical patent/DE2152814A1/de
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19712152814 1970-10-22 1971-10-22 Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung Ceased DE2152814A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB963871*[A GB1375162A (US08067413-20111129-C00011.png) 1970-10-22 1970-10-22
GB963871 1971-04-16

Publications (1)

Publication Number Publication Date
DE2152814A1 true DE2152814A1 (de) 1972-05-04

Family

ID=26243063

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19712152814 Ceased DE2152814A1 (de) 1970-10-22 1971-10-22 Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung

Country Status (7)

Country Link
KR (1) KR780000097B1 (US08067413-20111129-C00011.png)
DE (1) DE2152814A1 (US08067413-20111129-C00011.png)
GB (1) GB1375163A (US08067413-20111129-C00011.png)
HU (1) HU166528B (US08067413-20111129-C00011.png)
PH (1) PH9226A (US08067413-20111129-C00011.png)
RO (1) RO67383A (US08067413-20111129-C00011.png)
SU (1) SU429581A3 (US08067413-20111129-C00011.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2252807A1 (de) * 1971-12-01 1973-06-07 Hoffmann La Roche Neue benzylpyrimidine
DE2400218A1 (de) * 1973-01-05 1974-07-18 Wellcome Found Pharmazeutische formulierungen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2252807A1 (de) * 1971-12-01 1973-06-07 Hoffmann La Roche Neue benzylpyrimidine
DE2400218A1 (de) * 1973-01-05 1974-07-18 Wellcome Found Pharmazeutische formulierungen

Also Published As

Publication number Publication date
HU166528B (US08067413-20111129-C00011.png) 1975-03-28
PH9226A (en) 1975-07-15
RO67383A (ro) 1981-07-30
KR780000097B1 (en) 1978-04-08
GB1375163A (US08067413-20111129-C00011.png) 1974-11-27
SU429581A3 (ru) 1974-05-25

Similar Documents

Publication Publication Date Title
EP0005205B1 (de) Substituierte 5,6-Dimethylpyrrolo(2,3-d)pyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1795062A1 (de) 1H-Imidazo[4,5-b]pyrazin-2-one und Verfahren zu ihrer Herstellung
DE1303727B (de) Alpha-Arylidensubstituierte Propioni-Irile
DE2136950A1 (de) Pyrazolo(3,4 d)pynmidinderivate und deren Salze, Herstellung solcher Substanzen und Arzneimittel mit einem Gehalt daran
CH637385A5 (de) Verfahren zur herstellung von pyrimidin-derivaten und von deren pharmakologisch vertraeglichen salzen.
DE1965264A1 (de) Pyrazinoylsulfamide und Verfahren zu ihrer Herstellung
DE1695358A1 (de) Derivate des Tris(hydroxymethyl)aminomethans
DE60004671T2 (de) Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung
DE2408906A1 (de) 6-styrylpyrazolo(3,4-d)pyrimidin-4-one und -pyrimidine mit ihren salzen
DE1802394A1 (de) Aminoguanidine,Verfahren zu ihrer Herstellung und ihre Verwendung
DE2523103A1 (de) Neue propargyl-2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE2247186A1 (de) Antimykotisches mittel
DE1695133A1 (de) Verfahren zur Herstellung von Imidazolderivaten
DE2443682C2 (de) Neue 2,4-Diamino-5-benzylpyrimidine
DE2152814A1 (de) Pharmazeutisch wirksame Benzylpynmi dme, Verfahren xu ihrer Herstellung und ihre Verwendung
DE1965711C3 (de) l^-Dihydro-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2364685A1 (de) Phenoxyalkylamine und verfahren zu ihrer herstellung
DE2105580A1 (en) 3-aryl-benzisothiazole 1,1-dioxide derivs - which ar e non -hyperglycaemic hypotensives
DE1593762A1 (de) Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
DE2225433A1 (de) Aminopyrazolo(3,4-b)pyridin-5-ketone mit ihren Salzen, Herstellungsverfahren dafür und Arzneimittel daraus
DE2140865B2 (de) 1 -Imidazolyl-methanphosphonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2650366C3 (de) Verwendung eines 5-Fluoruracilde-
EP0012725B1 (de) Chinoxalin-Di-N-oxid-Derivate, Verfahren zu ihrer Herstellung, Mittel diese enthaltend und ihre Verwendung
DE2521920A1 (de) Neue derivate von 1h-triazolo(4,5-c) pyridin-7-carbonsaeuren und -saeureestern
DE2218220A1 (de) 2.4-Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen

Legal Events

Date Code Title Description
OD Request for examination
8131 Rejection